DaVita Inc.

149.56
-5.95 (-3.83%)
At close: Apr 14, 2025, 3:22 PM
-3.83%
Bid 149.39
Market Cap 11.96B
Revenue (ttm) 12.82B
Net Income (ttm) 936.34M
EPS (ttm) 10.73
PE Ratio (ttm) 13.94
Forward PE 15.14
Analyst Hold
Ask 150
Volume 999,944
Avg. Volume (20D) 930,214
Open 154.39
Previous Close 155.51
Day's Range 147.88 - 154.91
52-Week Range 125.64 - 179.60
Beta 1.04

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and manag...

Sector Healthcare
IPO Date Oct 31, 1995
Employees 76,000
Stock Exchange NYSE
Ticker Symbol DVA
Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $169, which is an increase of 13.00% from the latest price.

Stock Forecasts
1 month ago
-11.09%
DaVita shares are trading lower after the company ... Unlock content with Pro Subscription
1 month ago
+2.94%
DaVita shares are trading lower. The company reported Q4 financial results.